• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用稀有细胞分析系统追踪针对严重急性呼吸综合征冠状病毒2的B细胞记忆

Tracking B Cell Memory to SARS-CoV-2 Using Rare Cell Analysis System.

作者信息

Tsai Dong-Yan, Wang Chun-Hung, Schiro Perry G, Chen Nathan, Tseng Ju-Yu

机构信息

MiCareo Taiwan Co., Ltd., 5F, No. 69, Ln. 77, Xing Ai Rd., Neihu Dist., Taipei City 114, Taiwan.

Adimmune Corporation, No. 3, Sec.1, Tanxing Rd., Tanzi Dist., Taichung City 427, Taiwan.

出版信息

Vaccines (Basel). 2023 Mar 26;11(4):735. doi: 10.3390/vaccines11040735.

DOI:10.3390/vaccines11040735
PMID:37112647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10145117/
Abstract

Rapid mutations within SARS-CoV-2 are driving immune escape, highlighting the need for in-depth and routine analysis of memory B cells (MBCs) to complement the important but limited information from neutralizing antibody (nAb) studies. In this study, we collected plasma samples and peripheral blood mononuclear cells (PBMCs) from 35 subjects and studied the nAb titers and the number of antigen-specific memory B cells at designated time points before and after vaccination. We developed an assay to use the MiSelect R II System with a single-use microfluidic chip to directly detect the number of spike-receptor-binding domain (RBD)-specific MBCs in PBMCs. Our results show that the number of spike-RBD-specific MBCs detected by the MiSelect R II System is highly correlated with the level of nAbs secreted by stimulated PBMCs, even 6 months after vaccination when nAbs were generally not present in plasma. We also found antigen-specific cells recognizing Omicron spike-RBD were present in PBMCs from booster vaccination of subjects, but with a high variability in the number of B cells. The MiSelect R II System provided a direct, automated, and quantitative method to isolate and analyze subsets of rare cells for tracking cellular immunity in the context of a rapidly mutating virus.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的快速突变正在推动免疫逃逸,这凸显了对记忆B细胞(MBC)进行深入和常规分析的必要性,以补充来自中和抗体(nAb)研究的重要但有限的信息。在本研究中,我们收集了35名受试者的血浆样本和外周血单核细胞(PBMC),并研究了疫苗接种前后指定时间点的nAb滴度和抗原特异性记忆B细胞数量。我们开发了一种检测方法,使用带有一次性微流控芯片的MiSelect R II系统直接检测PBMC中刺突受体结合域(RBD)特异性MBC的数量。我们的结果表明,MiSelect R II系统检测到的刺突-RBD特异性MBC数量与受刺激PBMC分泌的nAb水平高度相关,即使在接种疫苗6个月后血浆中通常不存在nAb时也是如此。我们还发现,在接受加强疫苗接种的受试者的PBMC中存在识别奥密克戎刺突-RBD的抗原特异性细胞,但B细胞数量存在很大差异。MiSelect R II系统提供了一种直接、自动化和定量的方法,用于在快速突变病毒的背景下分离和分析稀有细胞亚群以追踪细胞免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/a264bc8bdfe9/vaccines-11-00735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/4186981ac546/vaccines-11-00735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/f9de7fe5709d/vaccines-11-00735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/a407ba6ed6f9/vaccines-11-00735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/38c1aa571acf/vaccines-11-00735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/b61b3a6deb76/vaccines-11-00735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/a264bc8bdfe9/vaccines-11-00735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/4186981ac546/vaccines-11-00735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/f9de7fe5709d/vaccines-11-00735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/a407ba6ed6f9/vaccines-11-00735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/38c1aa571acf/vaccines-11-00735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/b61b3a6deb76/vaccines-11-00735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/261d/10145117/a264bc8bdfe9/vaccines-11-00735-g006.jpg

相似文献

1
Tracking B Cell Memory to SARS-CoV-2 Using Rare Cell Analysis System.使用稀有细胞分析系统追踪针对严重急性呼吸综合征冠状病毒2的B细胞记忆
Vaccines (Basel). 2023 Mar 26;11(4):735. doi: 10.3390/vaccines11040735.
2
Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study.慢性肾脏病患者对重组和灭活新冠病毒疫苗的细胞和体液反应:一项观察性研究
J Clin Med. 2023 Feb 3;12(3):1225. doi: 10.3390/jcm12031225.
3
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.全面绘制 SARS-CoV-2 RBD 特异性中和抗体的结合热点,用于跟踪免疫逃逸变异株。
Genome Med. 2021 Oct 14;13(1):164. doi: 10.1186/s13073-021-00985-w.
4
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.感染或接种疫苗后针对 SARS-CoV-2 奥密克戎变异株的抗体亲合力和中和反应。
J Immunol Res. 2022 Aug 31;2022:4813199. doi: 10.1155/2022/4813199. eCollection 2022.
5
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study.代谢综合征患者中灭活 COVID-19 疫苗的安全性和免疫原性:一项横断面观察性研究。
Front Public Health. 2022 Dec 23;10:1067342. doi: 10.3389/fpubh.2022.1067342. eCollection 2022.
6
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine.两剂 BNT162b2 mRNA 疫苗可诱导产生针对 SARS-CoV-2 奥密克戎的中和记忆 B 细胞。
Sci Immunol. 2022 Apr 22;7(70):eabn8590. doi: 10.1126/sciimmunol.abn8590.
7
Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.人抗刺突蛋白受体结合域抗体对严重急性呼吸综合征冠状病毒中和逃逸及适应性的影响。
J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.
8
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination.尽管对 SARS-CoV-2 mRNA 疫苗接种的循环 T 细胞反应迅速收缩,但仍存在持久记忆。
Front Immunol. 2023 Feb 13;14:1100594. doi: 10.3389/fimmu.2023.1100594. eCollection 2023.
9
Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination.接种疫苗后抗SARS-CoV-2 RBD IgG与针对SARS-CoV-2奥密克戎变异株的中和抗体的相关性分析
Diagnostics (Basel). 2022 May 25;12(6):1315. doi: 10.3390/diagnostics12061315.
10
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.mRNA SARS-CoV-2 疫苗的第三剂加强了骨髓纤维化患者的刺突特异性抗体和记忆 B 细胞反应。
Front Immunol. 2022 Sep 29;13:1017863. doi: 10.3389/fimmu.2022.1017863. eCollection 2022.

本文引用的文献

1
The next generation of coronavirus vaccines: a graphical guide.下一代冠状病毒疫苗:图文指南。
Nature. 2023 Feb;614(7946):22-25. doi: 10.1038/d41586-023-00220-z.
2
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses.既往 SARS-CoV-2 感染与加强针接种间隔时间影响抗体和 B 细胞应答的幅度和质量。
Cell. 2022 Nov 10;185(23):4333-4346.e14. doi: 10.1016/j.cell.2022.09.032. Epub 2022 Sep 27.
3
The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination.
接种疫苗前的 SARS-CoV-2 特异性 T 细胞库决定了免疫反应的质量。
Immunity. 2022 Oct 11;55(10):1924-1939.e5. doi: 10.1016/j.immuni.2022.08.003. Epub 2022 Aug 12.
4
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.新冠病毒感染中适应性免疫区抗原受体库破坏的全球模式。
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2201541119. doi: 10.1073/pnas.2201541119. Epub 2022 Aug 9.
5
SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens.未暴露成年人中的 SARS-CoV-2 特异性 T 细胞具有广泛的归巢潜力,并与共生抗原发生交叉反应。
Sci Immunol. 2022 Oct 21;7(76):eabn3127. doi: 10.1126/sciimmunol.abn3127. Epub 2022 Oct 14.
6
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers.单剂量ChAdOx1 nCoV-19疫苗在既往感染过SARS-CoV-2的个体中引发的高抗体反应与两剂接种、未感染过SARS-CoV-2的个体相当:一项针对埃塞俄比亚医护人员的纵向研究。
Vaccines (Basel). 2022 May 27;10(6):859. doi: 10.3390/vaccines10060859.
7
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.对 SARS-CoV-2 感染和 COVID-19 疫苗的免疫记忆。
Immunol Rev. 2022 Sep;310(1):27-46. doi: 10.1111/imr.13089. Epub 2022 Jun 22.
8
Serum Neutralizing Antibody Titers 12 Months After Coronavirus Disease 2019 Messenger RNA Vaccination: Correlation to Clinical Variables in an Adult, US Population.新冠肺炎信使 RNA 疫苗接种 12 个月后血清中和抗体滴度:与美国成年人临床变量的相关性。
Clin Infect Dis. 2023 Feb 8;76(3):e391-e399. doi: 10.1093/cid/ciac416.
9
Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.化学发光免疫分析检测疫苗接种和康复 COVID-19 队列中中和抗体和结合抗体的纵向分布。
Immun Inflamm Dis. 2022 Jun;10(6):e612. doi: 10.1002/iid3.612.
10
Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination.先前存在的 SARS-CoV-2 免疫会影响对 SARS-CoV-2 疫苗接种的体液免疫反应的效力、广度和持久性。
Cell Rep Med. 2022 Mar 29;3(4):100603. doi: 10.1016/j.xcrm.2022.100603. eCollection 2022 Apr 19.